Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor
about
Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cellsRegulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritisSoluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine.Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin.Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity.The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types.APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophagesDistinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.Macrophage-derived chemokine (CCL22) is a novel mediator of lung inflammation following hemorrhage and resuscitation.The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
P2860
Q21245111-D4B81171-7BD6-4040-9F9D-0A0CC0FCCA1FQ28072580-4DC54CE9-52A2-468F-B11D-8C53962D41B3Q28567754-00690015-D544-4095-A617-6D55C6244834Q30427403-A16FA5EB-D84B-4003-98F6-A7D3277ECFA6Q34078439-614EC04D-1F44-4ECB-861F-55391ED1A262Q35198556-88516689-E0D8-43F6-80DF-C921EBECE4A1Q35746460-21ED33FD-2804-4994-AC34-E48E4A938D56Q36041103-4C4FCABA-B0E7-410C-8C82-CA8D39794EA5Q36736256-D68B5A32-E1CE-4ED6-B6E7-B41ACEFE3F93Q37006880-12C355D0-30D2-46D3-B1C7-F5DA04E69EC2Q37039316-C1EAA373-45E9-48F6-AB53-35C3419FBD8BQ37662609-E93B9A3D-5BAD-419E-9902-70DA5C4C45E2Q37706598-0A7C9AE2-4357-4403-8F16-45EE36D1491EQ38877913-E85D8CF5-C18E-4233-B936-A2450FEDE3EBQ41201376-8727D58E-02E3-4BE8-9C05-CB54BBDD5690Q41767306-D05D0E2E-D29E-4423-8B99-E6FA5266F3BEQ47114458-C003CC56-2B94-4634-BCB2-05D192DDA64B
P2860
Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@ast
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@en
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@en-gb
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@nl
type
label
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@ast
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@en
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@en-gb
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@nl
prefLabel
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@ast
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@en
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@en-gb
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@nl
P2093
P921
P3181
P1476
Enhanced anti-HIV-1 activity a ...... ply an additional MDC receptor
@en
P2093
P304
P3181
P407
P577
1998-09-15T00:00:00Z